‘Why do we value a Mars bar more than life-saving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics

A industry story from the U.S., reported by Fortune.

Industry · the U.S. · October 27, 2026

From Fortune

The Swiss pharmaceutical giant operates one of the last penicillin plants in Europe—losing it would raise new security and sovereignty challenges, says CEO Richard Saynor.

Reported by Fortune, October 27, 2026. Read the full story at Fortune →

More industry from the U.S.

20 Years of MacBook: How Apple shaped the laptops we use today · Engadget
Apple backports CoreGraphics zero-day patches to older iPhones · BleepingComputer
Nvidia to invest $3 billion in Meta as tech giants deepen AI partnership · CNBC Top News
How is P&G’s CEO getting inflation-weary shoppers to pay more? It starts with cashmere-like diapers · Fortune
HSBC announces share buyback of up to $1 billion as third-quarter profit meets estimates · CNBC Top News
Vance announces $57M grant boost for meatpacking facilities · The Hill
iPhone Lockdown Mode: The pros and cons of enabling Apple's security feature · Engadget
Apple confirms some reports of iPhone Duo cracking near the seam · CBS News

All industry →

Open HeyHomees →